TAG:
clinical trials
“April 30, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 6 – April 30, 2001 Issue
It seems some companies serving the laboratory industry have learned the importance of having a better understanding of the inner workings of Washington, DC. Both Cerner Corporation and Specialty Laboratories, Inc. will add Nancy-Ann DeParle to their respective Board…
New Cytology Technology Entering Study Phase
By Robert Michel | From the Volume VIII No. 5 – April 9, 2001 Issue
CEO SUMMARY: There’s a new contestant in the ongoing battle to win the Pap smear technology wars. Ampersand Medical Corporation, by signing a strategic alliance with AmeriPath, Inc., has signaled that it’s ready to bring its technology to market. AmeriPath will play a major role in ex…
Market Changes Lead LabCorp To Follow New Strategic Direction
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
CEO SUMMARY: When formed in 1995, Laboratory Corporation of America faced a financially-hostile marketplace for lab testing services. However, strategic planning retreats in 1997 and 1999 were pivotal in redirecting this billion-dollar lab behemoth toward financial stability. During 2000,…
Consumers Taking Active Role In Their Laboratory Testing
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
CEO SUMMARY: Two recent Internet surveys revealed that consumers rank access to their personal lab test results as the number one most wanted feature in healthcare services. This is an early warning for laboratories and pathology group practices. Today’s consumers have changing expectat…
Genetics Tidal Wave is Rapidly Approaching
By R. Lewis Dark | From the Volume VII No. 17 – December 4, 2000 Issue
EVERYONE IN THE CLINICAL LAB BUSINESS KNOWS that our business will soon be dominated by genetic and molecular testing technology. However, most lab administrators and pathologists believe that we are several years away from the widespread clinical use of such technology in laboratory testing. In pr…
“December 4, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
Evidence continues to grow that consumers are using the Internet to actively intervene in their health care. The Pew Foundation released a report last week that says 52 million Americans are using the Internet “to gain knowledge about disease, investigate how to participate in clinic…
Omnicom Group, CareSoft, eMedicine.com, Verisign, RSA Security
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
AD AGENCIES PREPARING “DIRECT TO PATIENT” MARKETING CAMPAIGNS HERE’S MORE EVIDENCE that healthcare providers like laboratories and pathology groups will increasingly market their services directly to consumers. One of the largest consolidated advertising agencies in the world has take…
Neurology is Test Focus For Athena Diagnostics
CEO SUMMARY: There are few examples of laboratory companies focused on a single medical specialty,a business model that is expected to become more common in coming years. One such company is Athena Diagnostics. For 12 years, this company has concentrated on providing diagnostic testing fo…
Questions Remain About Performance Of Liquid-Prep Paps
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: During the past five years, several companies entered the lab marketplace with claims that their new Pap test technologies are improvements over conventional Pap smear methods. Armed with investment capital from Wall Street, these companies launched aggressive sales and marke…
Columbia/HCA, AmeriPath, Epitope, STC Technologies, Quest Diagnostics
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
COLUMBIA/HCA GETS NEW NAME; ACQUIRES FOUR LONDON HOSPITALS NOW THAT IT HAS A SETTLEMENT with the federal government on civil claims of Medicare fraud, expect a rapid cascade of changes at Columbia/HCA Healthcare Corporation, the nation’s largest for-profit hospital company…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized